title: Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study.
abstract: BACKGROUND
  Premature myocardial infarction with life-threatening complications may become epidemic in some Asian and African countries and especially Iran. Fibrinogen is considered as one of the probable risk factors of myocardial infarction. The aim of our study was to assess fibrinogen levels as an etiology of premature myocardial infarction in young Iranian men.
  
  
  RESULTS
  A case-control study was conducted between May 2005 and May 2007 to investigate the association between serum total fibrinogen level and myocardial infarction in men aged younger than 55 years admitted to the cardiac care units of Peymanieh and Motahari Hospitals affiliated to Jahrom University of Medical Sciences, Iran. The mean age of patients was 45.2 +/- 4 years in patients with premature myocardial infarction and 47.06 +/- 4.5 years in the control group (p = 0.085). There were no statistically significant relationships between the two groups in history of premature myocardial infarction in their first-degree relatives (p = 0.05), cigarette smoking (p = 0.46), diabetes (p = 0.49), or hypertension (p = 1). The mean plasma fibrinogen in patients (354.9 +/- 60 mg/dL) was elevated markedly compared with the control group (329 +/- 73 mg/dL). Hyperfibrinogenemia (>340 mg/dL) was detected in 81.8% of patients and 57.5% of controls (95% confidence interval, odds ratio = 3.3; p = 0.036).
  
  
  CONCLUSIONS
  This study introduced fibrinogen as a risk factor for premature coronary artery disease in Iranian men.
authors.affiliation: Peymanieh Hospital, Internal Medicine Department, Jahrom University of Medical Sciences, Jahrom, Fars, Iran.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Shojaie
authors.forename: Morteza
authors.initials: M
authors.lastname: Pourahmad
authors.forename: Ahad
authors.initials: A
authors.lastname: Eshraghian
authors.forename: Hamid Reza
authors.initials: HR
authors.lastname: Izadi
authors.forename: Farzan
authors.initials: F
authors.lastname: Naghshvar
mesh_terms: D000328:Adult; D017668:Age of Onset; D044466:Asian People / Q000706:statistics & numerical data*; D015415:Biomarkers; D016022:Case-Control Studies; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000208:ethnology / Q000209:etiology*; D016017:Odds Ratio; D018570:Risk Assessment; D012307:Risk Factors; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D005340:Fibrinogen
references.citation: Kardiol Pol. 2003 Sep;59(9):205-12
references.pmid: 14618197
references.citation: Eur Heart J. 1995 Mar;16 Suppl A:11-4; discussion 14-5
references.pmid: 7796823
references.citation: Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1065-70
references.pmid: 11397721
references.citation: Eur Heart J. 2000 Apr;21(7):515-20
references.pmid: 10775006
references.citation: Eur Heart J. 1995 Mar;16 Suppl A:21-3; discussion 23-4
references.pmid: 7796826
references.citation: N Engl J Med. 1984 Aug 23;311(8):501-5
references.pmid: 6749207
references.citation: AMA Arch Intern Med. 1954 Feb;93(2):231-45
references.pmid: 13123552
references.citation: Am J Cardiol. 2002 Mar 15;89(6):662-6
references.pmid: 11897206
references.citation: Circulation. 1997 Aug 19;96(4):1102-8
references.pmid: 9286936
references.citation: Lancet. 1976 Nov 27;2(7996):1161-4
references.pmid: 62994
references.citation: Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):452-8
references.pmid: 11231928
references.citation: Saudi Med J. 2007 Sep;28(9):1350-2
references.pmid: 17768458
references.citation: Eur Heart J. 1995 Mar;16 Suppl A:2-5
references.pmid: 7796825
references.citation: Vasc Med. 1997;2(2):115-25
references.pmid: 9546953